Keyphrases
Systemic Sclerosis
100%
Dermal Fibrosis
100%
Allogeneic
100%
Marrow Transplantation
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
80%
Graft-versus-host Disease (GvHD)
80%
Scleroderma
40%
Hematopoietic Cell Transplantation
40%
Conditioning Regimen
40%
Opportunistic Infections
40%
Myeloablative Conditioning
40%
Transplantation
20%
Skin Biopsy
20%
Immunosuppressive Therapy
20%
Lung
20%
Bone Marrow
20%
Internal Organs
20%
Poor Prognosis
20%
Biopsy Specimen
20%
Infectious Diseases
20%
Physical Functioning
20%
Organ Function
20%
Cyclophosphamide
20%
Methotrexate
20%
Cyclosporine
20%
No Complication
20%
Sustained Remission
20%
Busulfan
20%
Major Risk
20%
Overall Functioning
20%
Antithymocyte Globulin
20%
Diffuse Cutaneous Systemic Sclerosis
20%
Complete Resolution
20%
HLA-identical Sibling
20%
Lung Involvement
20%
High-dose Corticosteroids
20%
Skin Toxicity
20%
Hypertensive Crisis
20%
Medicine and Dentistry
Systemic Scleroderma
100%
Hematopoietic Cell
100%
Cell Transplantation
100%
Skin Fibrosis
100%
Graft Versus Host Reaction
66%
Opportunistic Infection
33%
Conditioning
33%
Myeloablative Conditioning
33%
Lung
33%
Scleroderma
33%
Immunosuppressive Treatment
16%
Cyclophosphamide
16%
Drug Megadose
16%
Thymocyte Antibody
16%
Biopsy Sample
16%
Cyclosporine
16%
Skin Toxicity
16%
Skin Biopsy
16%
Hypertensive Crisis
16%
Methotrexate
16%
Busulfan
16%
Immunology and Microbiology
Systemic Scleroderma
100%
Cell Transplantation
100%
Hematopoietic Cell
100%
Graft-Versus-Host Disease
66%
Conditioning
66%
Scleroderma
33%
Opportunistic Infection
33%
Immunosuppressive Drug
16%
Drug Megadose
16%
Methotrexate
16%
Ciclosporin
16%
Anti-Thymocyte Globulin
16%
Cyclophosphamide
16%
Pharmacology, Toxicology and Pharmaceutical Science
Systemic Sclerosis
100%
Skin Fibrosis
100%
Graft Versus Host Reaction
66%
Opportunistic Infection
33%
Scleroderma
33%
Busulfan
16%
Remission
16%
Cyclophosphamide
16%
Methotrexate
16%
Ciclosporin
16%
Immunosuppressive Agent
16%
Thymocyte Antibody
16%
Skin Toxicity
16%
Hypertensive Crisis
16%